{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:00:38Z","timestamp":1765422038965,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"FCT-Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia fellowship","award":["SFRH\/SINTD\/94217\/2013"],"award-info":[{"award-number":["SFRH\/SINTD\/94217\/2013"]}]},{"name":"Research Center of Portuguese Oncology Institute \u2013 Porto","award":["CI-IPOP 4-2012","CI-IPOP 27"],"award-info":[{"award-number":["CI-IPOP 4-2012","CI-IPOP 27"]}]},{"name":"Associa\u00e7\u00e3o Portuguesa de Urologia (APU)","award":["APU 2010"],"award-info":[{"award-number":["APU 2010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12967-017-1248-y","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T11:36:31Z","timestamp":1498736191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel"],"prefix":"10.1186","volume":"15","author":[{"given":"Ana S\u00edlvia","family":"Pires-Lu\u00eds","sequence":"first","affiliation":[]},{"given":"Pedro","family":"Costa-Pinheiro","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Lobo","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrneph.2016.168","volume":"13","author":"MR Morris","year":"2016","unstructured":"Morris MR, Latif F. The epigenetic landscape of renal cancer. Nat Rev Nephrol. 2016;13:47\u201360.","journal-title":"Nat Rev Nephrol"},{"key":"1248_CR2","doi-asserted-by":"crossref","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumours of the urinary system and male genital organs. Lyon: IARC; 2016.","DOI":"10.1016\/j.eururo.2016.02.029"},{"key":"1248_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.urolonc.2009.07.024","volume":"29","author":"MJ Fernandez-Acenero","year":"2011","unstructured":"Fernandez-Acenero MJ, Cazorla A, Manzarbeitia F. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features. Urol Oncol. 2011;29:545\u20139.","journal-title":"Urol Oncol"},{"key":"1248_CR4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bju.12470","volume":"113","author":"M Tsivian","year":"2014","unstructured":"Tsivian M, Rampersaud EN Jr, del Pilar Laguna Pes M, Joniau S, Leveillee RJ, Shingleton WB, Aron M, Kim CY, DeMarzo AM, Desai MM. Small renal mass biopsy\u2014how, what and when: report from an international consensus panel. BJU Int. 2014;113:854\u201363.","journal-title":"BJU Int"},{"key":"1248_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0b013e31821e25cd","volume":"35","author":"HA Al-Ahmadie","year":"2011","unstructured":"Al-Ahmadie HA, Alden D, Fine SW, Gopalan A, Touijer KA, Russo P, Reuter VE, Tickoo SK. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am J Surg Pathol. 2011;35:949\u201361.","journal-title":"Am J Surg Pathol"},{"key":"1248_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500.","journal-title":"Nat Rev Genet"},{"key":"1248_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.canlet.2011.12.026","volume":"342","author":"C Jeronimo","year":"2014","unstructured":"Jeronimo C, Henrique R. Epigenetic biomarkers in urological tumors: a systematic review. Cancer Lett. 2014;342:264\u201374.","journal-title":"Cancer Lett"},{"key":"1248_CR8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fgene.2012.00094","volume":"3","author":"R Henrique","year":"2012","unstructured":"Henrique R, Luis AS, Jeronimo C. The epigenetics of renal cell tumors: from biology to biomarkers. Front Genet. 2012;3:94.","journal-title":"Front Genet"},{"key":"1248_CR9","first-page":"157","volume":"68","author":"AH Rosa la","year":"2015","unstructured":"la Rosa AH, Acker M, Swain S, Manoharan M. The role of epigenetics in kidney malignancies. Cent Eur J Urol. 2015;68:157\u201364.","journal-title":"Cent Eur J Urol"},{"key":"1248_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-015-0180-y","volume":"8","author":"N Shenoy","year":"2015","unstructured":"Shenoy N, Vallumsetla N, Zou Y, Galeas JN, Shrivastava M, Hu C, Susztak K, Verma A. Role of DNA methylation in renal cell carcinoma. J Hematol Oncol. 2015;8:88.","journal-title":"J Hematol Oncol"},{"key":"1248_CR11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.bjc.6603482","volume":"95","author":"F Christoph","year":"2006","unstructured":"Christoph F, Kempkensteffen C, Weikert S, Kollermann J, Krause H, Miller K, Schostak M, Schrader M. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br J Cancer. 2006;95:1701\u20137.","journal-title":"Br J Cancer"},{"key":"1248_CR12","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1158\/1078-0432.CCR-06-0144","volume":"12","author":"F Christoph","year":"2006","unstructured":"Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Kollermann J, Miller K, Schrader M. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res. 2006;12:5040\u20136.","journal-title":"Clin Cancer Res"},{"key":"1248_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-7-133","volume":"7","author":"VL Costa","year":"2007","unstructured":"Costa VL, Henrique R, Ribeiro FR, Pinto M, Oliveira J, Lobo F, Teixeira MR, Jeronimo C. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer. 2007;7:133.","journal-title":"BMC Cancer"},{"key":"1248_CR14","first-page":"64","volume":"32","author":"AS Pires-Lu\u00eds","year":"2015","unstructured":"Pires-Lu\u00eds AS, Lobo F, Vieira-Coimbra M, Costa-Pinheiro P, Antunes L, Oliveira J, Henrique R, Jer\u00f3nimo C. MST1R methylation as a diagnostic biomarker in renal cell tumors. Acta Urol Port. 2015;32:64\u201370.","journal-title":"Acta Urol Port"},{"key":"1248_CR15","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-04-3371","volume":"65","author":"MR Morris","year":"2005","unstructured":"Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2\/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res. 2005;65:4598\u2013606.","journal-title":"Cancer Res"},{"key":"1248_CR16","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/0008-5472.CAN-05-3365","volume":"66","author":"II Caceres de","year":"2006","unstructured":"de Caceres II, Dulaimi E, Hoffman AF, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 2006;66:5021\u20138.","journal-title":"Cancer Res"},{"key":"1248_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.juro.2008.02.044","volume":"180","author":"I Kagara","year":"2008","unstructured":"Kagara I, Enokida H, Kawakami K, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Itesako T, Kawamoto K, et al. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. J Urol. 2008;180:343\u201351.","journal-title":"J Urol"},{"key":"1248_CR18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6604180","volume":"98","author":"MR Morris","year":"2008","unstructured":"Morris MR, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Teh BT, Latif F, Maher ER. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer. 2008;98:496\u2013501.","journal-title":"Br J Cancer"},{"key":"1248_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-8-31","volume":"8","author":"FE McRonald","year":"2009","unstructured":"McRonald FE, Morris MR, Gentle D, Winchester L, Baban D, Ragoussis J, Clarke NW, Brown MD, Kishida T, Yao M, et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol Cancer. 2009;8:31.","journal-title":"Mol Cancer"},{"key":"1248_CR20","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/onc.2009.493","volume":"29","author":"MR Morris","year":"2010","unstructured":"Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F, Maher ER. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene. 2010;29:2104\u201317.","journal-title":"Oncogene"},{"key":"1248_CR21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/onc.2010.525","volume":"30","author":"MR Morris","year":"2011","unstructured":"Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, Brown M, Kishida T, Yao M, Banks RE, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene. 2011;30:1390\u2013401.","journal-title":"Oncogene"},{"key":"1248_CR22","doi-asserted-by":"crossref","first-page":"e77309","DOI":"10.1371\/journal.pone.0077309","volume":"8","author":"I Ibragimova","year":"2013","unstructured":"Ibragimova I, Slifker MJ, Maradeo ME, Banumathy G, Dulaimi E, Uzzo RG, Cairns P. Genome-wide promoter methylome of small renal masses. PLoS ONE. 2013;8:e77309.","journal-title":"PLoS ONE"},{"key":"1248_CR23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4161\/epi.23817","volume":"8","author":"AA Slater","year":"2013","unstructured":"Slater AA, Alokail M, Gentle D, Yao M, Kovacs G, Maher ER, Latif F. DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma. Epigenetics. 2013;8:252\u201367.","journal-title":"Epigenetics"},{"key":"1248_CR24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/jcmm.12090","volume":"17","author":"P Patricio","year":"2013","unstructured":"Patricio P, Ramalho-Carvalho J, Costa-Pinheiro P, Almeida M, Barros-Silva JD, Vieira J, Dias PC, Lobo F, Oliveira J, Teixeira MR, et al. Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis. J Cell Mol Med. 2013;17:1048\u201358.","journal-title":"J Cell Mol Med"},{"key":"1248_CR25","first-page":"1799","volume":"6","author":"AS Pires-Luis","year":"2016","unstructured":"Pires-Luis AS, Vieira-Coimbra M, Ferreira MJ, Ramalho-Carvalho J, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Graca I, et al. Prognostic significance of MST1R dysregulation in renal cell tumors. Am J Cancer Res. 2016;6:1799\u2013811.","journal-title":"Am J Cancer Res"},{"key":"1248_CR26","first-page":"283","volume":"4","author":"RR Leao","year":"2015","unstructured":"Leao RR, Richard PO, Jewett MA. Indications for biopsy and the current status of focal therapy for renal tumours. Transl Androl Urol. 2015;4:283\u201393.","journal-title":"Transl Androl Urol"},{"key":"1248_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1756287215585273","volume":"7","author":"ML Blute Jr","year":"2015","unstructured":"Blute ML Jr, Drewry A, Abel EJ. Percutaneous biopsy for risk stratification of renal masses. Ther Adv Urol. 2015;7:265\u201374.","journal-title":"Ther Adv Urol"},{"key":"1248_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2008.09.009","volume":"40","author":"L Cheng","year":"2009","unstructured":"Cheng L, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 2009;40:10\u201329.","journal-title":"Hum Pathol"},{"key":"1248_CR29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4161\/epi.6.9.16376","volume":"6","author":"VL Costa","year":"2011","unstructured":"Costa VL, Henrique R, Danielsen SA, Eknaes M, Patricio P, Morais A, Oliveira J, Lothe RA, Teixeira MR, Lind GE, Jeronimo C. TCF21 and PCDH17 methylation: an innovative panel of biomarkers for a simultaneous detection of urological cancers. Epigenetics. 2011;6:1120\u201330.","journal-title":"Epigenetics"},{"key":"1248_CR30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1464-410X.2010.09468.x","volume":"107","author":"J Ellinger","year":"2011","unstructured":"Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Muller SC, Bastian PJ. DNA hypermethylation in papillary renal cell carcinoma. BJU Int. 2011;107:664\u20139.","journal-title":"BJU Int"},{"key":"1248_CR31","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.18632\/oncotarget.12276","volume":"8","author":"S Chopra","year":"2017","unstructured":"Chopra S, Liu J, Alemozaffar M, Nichols PW, Aron M, Weisenberger DJ, Collings CK, Syan S, Hu B, Desai M, et al. Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers. Oncotarget. 2017;8:5439\u201348.","journal-title":"Oncotarget"},{"key":"1248_CR32","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1158\/0008-5472.CAN-04-0799","volume":"64","author":"MO Hoque","year":"2004","unstructured":"Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 2004;64:5511\u20137.","journal-title":"Cancer Res"},{"key":"1248_CR33","first-page":"8695","volume":"63","author":"C Battagli","year":"2003","unstructured":"Battagli C, Uzzo RG, Dulaimi E, de Caceres II, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res. 2003;63:8695\u20139.","journal-title":"Cancer Res"},{"key":"1248_CR34","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/bjc.2013.552","volume":"109","author":"RM Silva-Santos","year":"2013","unstructured":"Silva-Santos RM, Costa-Pinheiro P, Luis A, Antunes L, Lobo F, Oliveira J, Henrique R, Jeronimo C. MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis. Br J Cancer. 2013;109:2646\u201353.","journal-title":"Br J Cancer"},{"key":"1248_CR35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bju.13630","volume":"119","author":"PO Richard","year":"2017","unstructured":"Richard PO, Jewett MA, Tanguay S, Saarela O, Liu ZA, Pouliot F, Kapoor A, Rendon R, Finelli A. Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry. BJU Int. 2017;119:543\u20139.","journal-title":"BJU Int."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T12:41:19Z","timestamp":1569588079000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1248-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1248-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2017,6,29]]},"article-number":"149"}}